Recruiting
Phase 1
Phase 2

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05691491

Conditions

Advanced Malignant Solid Neoplasm

Advanced Microsatellite Stable Colorectal Carcinoma

Hematopoietic and Lymphatic System Neoplasm

Metastatic Malignant Solid Neoplasm

Metastatic Microsatellite Stable Colorectal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Temozolomide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information